Home>>Analytical Standards>> Reference Materials>>Methoxmetamine (hydrochloride)

Methoxmetamine (hydrochloride) (Synonyms: 3-methoxy-2-oxo PCM, MMXE, MXM)

Catalog No.GC44176

Methoxmetamine (hydrochloride) is an analytical reference material that is structurally categorized as an amphetamine.

Products are for research use only. Not for human use. We do not sell to patients.

Methoxmetamine (hydrochloride) Chemical Structure

Cas No.: 1781829-56-8

Size Price Stock Qty
1mg
$111.00
In stock
5mg
$258.00
In stock
50mg
$1,616.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Methoxmetamine (hydrochloride) is an analytical reference material that is structurally categorized as an amphetamine. It has been identified in ingredients sold as designer drugs. The physiological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

Reviews

Review for Methoxmetamine (hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Methoxmetamine (hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.